SEC Form 4 · accession 0001179110-17-014854
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P. Quinn
Officer — CFO,Sr.V.P. Finance, Corp.Dev.
Period of report
Nov 30, 2017
Accepted (ET)
Dec 4, 2017 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.89 | Nov 30, 2017 | A | 232,500 | A | — | Nov 30, 2027 | Common Stock | 232,500 | 232,500 | D |
Explanation of responses
- F1Twenty-Five (25%) of the shares subject to the option will vest on November 30, 2018, the first anniversary of the effective date, and the remaining shares vest in thirty-six (36) equal monthly installments thereafter, until either the option is fully vested or Mr. Quinn's employment ends, whichever occurs first.